Almost every night for six months, my wife Erna has opened her eyes at 3:30, sometimes 4, with her body already tense. No worry she can name, no way back to sleep. Fifteen years ago in New York, she told me she couldn't get up before 7, no matter what she did. Now her body wakes her in the dark. Erna has read and approved every word of this episode, because she wants this out in the open.
This episode is the simplified version: broad strokes, so it's easy to follow. I explain what estrogen and progesterone do, what changes in perimenopause and menopause, and why the symptoms are so mixed. A large 2026 analysis found insomnia symptoms in about 27% of women in perimenopause and 42% after menopause. Then I look at three things that seem to work together to break sleep: the brain's thermostat, a missing calm, and an alarm the brain learns.
In this episode:
- What estrogen and progesterone do, explained over coffee.
- Menopause, perimenopause, and why the hormones swing before they drop.
- Why night hot flashes can wake you even when you don't notice them. In one study of 168 women, the odds of waking were over five times higher during a measured flash.
- GABA, the brain's brake pedal, and why progesterone matters for sleep.
- How the brain learns to wake, and why I couldn't find good evidence for the "3am cortisol spike."
- A progestin prescribed for sleep, and why that prescription needed a second look.
- The 2002 Women's Health Initiative scare in absolute numbers, and the FDA's 2026 label change.
- What helps: hormone therapy, micronized progesterone, and CBT-I, which in one trial brought 70% of the assessed women in the CBT-I group out of the insomnia range in 8 weeks, against 24% with education alone.
- What to do if you're the one sleeping next to it.
The episode closes with questions to take to your next appointment.
[Visit The Upward ARC and subscribe](https://www.andreheeg.com).
Under Load is the Sunday edition of The Upward ARC, by Andre Heeg, MD, DDS, physician and reconstructive facial surgeon. This edition sits within the Recover pillar, with Activate: helping the nervous system return to baseline, and sleep as a daily input.
This episode is general health education, not individual medical advice. For your own symptoms or decisions, talk to your doctor.
### Key sources
- [Merck Manual Consumer Version, 2026](https://www.merckmanuals.com/home/women-s-health-issues/menopause/menopause): Menopause.
- [McEvoy & Osborne, 2019](https://doi.org/10.1080/09540261.2018.1553775): Allopregnanolone and reproductive psychiatry: An overview.
- [Balasubramanian et al., 2026](https://doi.org/10.1016/j.genhosppsych.2026.03.010): Prevalence and incidence of depressive, anxiety, and insomnia symptoms in perimenopausal and postmenopausal women: Systematic review and meta-analysis.
- [Prague et al., 2017](https://doi.org/10.1016/S0140-6736(17)30823-1): Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: A phase 2, randomised, double-blind, placebo-controlled trial.
- [Thurston et al., 2019](https://doi.org/10.1093/sleep/zsz131): Hot flashes and awakenings among midlife women.
- [Fachinfo-Service, n.d.](https://www.fachinfo.de/fi/detail/013955/jubrele): Jubrele 75 Mikrogramm Filmtabletten: Fachinformation (Desogestrel).
- [Nolan et al., 2021](https://doi.org/10.1210/clinem/dgaa873): Efficacy of micronized progesterone for sleep: A systematic review and meta-analysis of randomized controlled trial data.
- [British Menopause Society, n.d.](https://thebms.org.uk/wp-content/uploads/2023/04/14-BMS-TfC-Progestogens-and-endometrial-protection-APR2023-A.pdf): Progestogens and endometrial protection [BMS Tools for Clinicians].
- [Rossouw et al., 2002](https://doi.org/10.1001/jama.288.3.321): Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial.
- [U.S. Food and Drug Administration, 2026](https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products): FDA approves labeling changes to menopausal hormone therapy products [Press release]..
- [The North American Menopause Society, 2022](https://doi.org/10.1097/GME.0000000000002028): The 2022 hormone therapy position statement of The North American Menopause Society.
- [Cintron et al., 2017](https://doi.org/10.1007/s12020-016-1072-9): Efficacy of menopausal hormone therapy on sleep quality: Systematic review and meta-analysis.
- [Edinger et al., 2021](https://doi.org/10.5664/jcsm.8986): Behavioral and psychological treatments for chronic insomnia disorder in adults: An American Academy of Sleep Medicine clinical practice guideline.
- [McCurry et al., 2016](https://doi.org/10.1001/jamainternmed.2016.1795): Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: A MsFLASH randomized clinical trial.
- [somnio, 2025](https://somn.io/fachkreise/somnio-verschreiben/): So verordnen Sie somnio Ihren Patient:innen..
- [Dunietz et al., 2026](https://doi.org/10.1016/j.chest.2025.08.001): OSA in women: Associations with reproductive aging and screening challenges.
### Audio note
The recording is the written edition adjusted for listening. Some figures are rounded, and citations are left out. Every study is referenced in the written edition at andreheeg.com.
### How I use AI
AI assisted with research, drafting and adapting this piece for different formats. I chose the argument and examples, reviewed the evidence, edited the final text and take responsibility for every published claim.